Release test results
99.553%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.03 mg
Related impurities (total)0.447%
Endotoxin<1.0 EU/mg
HPLC retention time6.04 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundIpamorelin
Presentation10 MG
Lot numberRGX-26-IPAMORELIN-655
COA numberNS-2026-05166
Test date13 Jan 2026
Release date16 Jan 2026
Independent labNordicstar Labs
StatusSuperseded
Ipamorelin — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-IPAMORELIN-1044 | 5 MG | Jul 17, 2026 | 99.608% | Current |
| RGX-26-IPAMORELIN-1045 | 10 MG | Jul 16, 2026 | 99.715% | Current |
| RGX-26-IPAMORELIN-755 | 10 MG | Apr 16, 2026 | 99.660% | Superseded |
| RGX-26-IPAMORELIN-756 | 5 MG | Mar 30, 2026 | 99.584% | Superseded |
| RGX-26-IPAMORELIN-656 | 5 MG | Jan 16, 2026 | 99.698% | Superseded |
| RGX-26-IPAMORELIN-655 this lot | 10 MG | Jan 13, 2026 | 99.553% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →